Investigational Drug Services Residency Program The Yale New Haven Hospital PGY2 in Investigational Drug Services (IDS) was established in 2020 and has been accredited since 2021. The PGY2 Investigational Drugs and Research Pharmacy Residency consists of a series of learning experiences that span a 52-week period. The residency program is designed to develop skilled clinical research pharmacists who provide exceptional pharmaceutical care to research patients, and are leaders who can manage ever-changing landscape of research pharmacy. Multiple electives allow the resident to tailor learningto their interests, with ~ 50% of learning experiences focused on oncology practice settings, and others provide experience in critical care and ambulatory care settings